Organogenesis Holdings Inc. (ORGO)
NASDAQ: ORGO · Real-Time Price · USD
2.360
-0.080 (-3.28%)
At close: Jul 2, 2026, 4:00 PM EDT
2.390
+0.030 (1.27%)
After-hours: Jul 2, 2026, 5:59 PM EDT
Organogenesis Holdings Market Cap
Organogenesis Holdings has a market cap or net worth of $303.67 million as of July 2, 2026. Its market cap has decreased by -23.52% in one year.
Market Cap
303.67M
Enterprise Value
283.15M
1-Year Change
-23.52%
Ranking
Category
Stock Price
$2.36
Market Cap Chart
Since January 8, 2019, Organogenesis Holdings's market cap has decreased from $1.24B to $303.67M, a decrease of -75.44%. That is a compound annual growth rate of -17.10%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 2, 2026 | 303.67M | -53.81% |
| Dec 31, 2025 | 657.40M | 63.40% |
| Dec 31, 2024 | 402.32M | -25.09% |
| Dec 29, 2023 | 537.07M | 52.51% |
| Dec 30, 2022 | 352.16M | -70.37% |
| Dec 31, 2021 | 1.19B | 23.61% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jan 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Evolus | 454.40M |
| Kamada | 432.96M |
| Emergent BioSolutions | 427.22M |
| Canopy Growth | 422.05M |
| Akebia Therapeutics | 332.64M |
| Alpha Teknova | 310.43M |
| SIGA Technologies | 276.86M |
| Anika Therapeutics | 204.37M |